These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34152015)

  • 1. Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF-κB pathway.
    Tu S; Jiang Y; Cheng H; Yuan X; He Y; Peng Y; Peng X; Peng Z; Tao L; Yang H
    FASEB J; 2021 Jul; 35(7):e21497. PubMed ID: 34152015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorofenidone attenuates inflammation by inhibiting the NF-кB pathway.
    Huang L; Zhang F; Tang Y; Qin J; Peng Y; Wu L; Wang F; Yuan Q; Peng Z; Liu J; Meng J; Tao L
    Am J Med Sci; 2014 Jul; 348(1):75-80. PubMed ID: 24534785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.
    Peng Y; Yang H; Wang N; Ouyang Y; Yi Y; Liao L; Shen H; Hu G; Wang Z; Tao L
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G253-63. PubMed ID: 24337009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.
    Wang H; Zhang J; Zhang X; Zhao N; Zhou Z; Tao L; Fu L; Peng S; Chai J
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166556. PubMed ID: 36154893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
    Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
    Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis.
    Chen H; Gan Q; Yang C; Peng X; Qin J; Qiu S; Jiang Y; Tu S; He Y; Li S; Yang H; Tao L; Peng Y
    J Transl Med; 2019 Aug; 17(1):280. PubMed ID: 31443720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorofenidone inhibits macrophage IL-1β production by suppressing inflammasome activity.
    Lu M; Yang W; Peng Z; Zhang J; Mei W; Liu C; Tang J; Ma H; Yuan X; Meng J; Lv B; Liu J; Hu G; Tao L
    Int Immunopharmacol; 2015 Jul; 27(1):148-53. PubMed ID: 25983199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.
    Peng Y; Yang H; Zhu T; Zhao M; Deng Y; Liu B; Shen H; Hu G; Wang Z; Tao L
    Eur J Clin Invest; 2013 Apr; 43(4):358-68. PubMed ID: 23438945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
    Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
    Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
    Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
    J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway.
    Dai Q; Zhang Y; Liao X; Jiang Y; Lv X; Yuan X; Meng J; Xie Y; Peng Z; Yuan Q; Tao L; Huang L
    Front Pharmacol; 2020; 11():534775. PubMed ID: 33390935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorofenidone attenuates renal fibrosis by inhibiting the mtROS-NLRP3 pathway in a murine model of folic acid nephropathy.
    Liao X; Jiang Y; Dai Q; Yu Y; Zhang Y; Hu G; Meng J; Xie Y; Peng Z; Tao L
    Biochem Biophys Res Commun; 2021 Jan; 534():694-701. PubMed ID: 33220928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
    Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
    Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway.
    Gu L; He X; Zhang Y; Li S; Tang J; Ma R; Yang X; Huang H; Peng Y; Xie Y; Peng Z; Meng J; Hu G; Tao L; Liu X; Yang H
    Biomed Pharmacother; 2023 Aug; 164():114844. PubMed ID: 37224750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis.
    Qin J; Xie YY; Huang L; Yuan QJ; Mei WJ; Yuan XN; Hu GY; Cheng GJ; Tao LJ; Peng ZZ
    Nephrology (Carlton); 2013 Oct; 18(10):690-9. PubMed ID: 23841831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways.
    Peng Y; Li L; Zhang X; Xie M; Yang C; Tu S; Shen H; Hu G; Tao L; Yang H
    Exp Ther Med; 2019 Jul; 18(1):41-48. PubMed ID: 31258636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial Function.
    Liu W; Zhou H; Dong H; Xing D; Lu M
    Cell Biochem Biophys; 2023 Dec; 81(4):777-785. PubMed ID: 37735328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorofenidone attenuates oxidative stress and renal fibrosis in obstructive nephropathy via blocking NOX2 (gp91phox) expression and inhibiting ERK/MAPK signaling pathway.
    Qin J; Mei WJ; Xie YY; Huang L; Yuan QJ; Hu GY; Tao LJ; Peng ZZ
    Kidney Blood Press Res; 2015; 40(1):89-99. PubMed ID: 26029782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
    Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
    J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorofenidone protects mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-1beta release.
    Tang Y; Li B; Wang N; Xie Y; Wang L; Yuan Q; Zhang F; Qin J; Peng Z; Ning W; Wang L; Hu G; Li J; Tao L
    Int Immunopharmacol; 2010 May; 10(5):580-3. PubMed ID: 20159052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.